Fig. 4From: In silico formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic feverGraph represented the RMSD values of the vaccine and vaccine complex. V1 (light blue), V2 (orange), TLR4-V1 (ash), TLR3-V2 (yellow), and TLR8-V2 (blue) are represented hereBack to article page